We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Refer Branded Drugmakers to FTC for Using Citizen Petitions to Block Generics
FDA to Refer Branded Drugmakers to FTC for Using Citizen Petitions to Block Generics
FDA Commissioner Scott Gottlieb announced new guidance Tuesday to address efforts by branded drugmakers to use the citizen petition process to stifle competition.